论文部分内容阅读
动态测定了35例急性心肌梗塞血清肌酸磷酸激酶同功酶(CPK-MB)时间-活性变化曲线,探讨对估测心肌梗塞范围(MIS)的临床意义及缺少早期测定值对估测MIS的影响程度、校正方法。结果表明,MIS的大小是决定预后的重要因素,当MIS在60CPK-MB-g-Eq以上,病死率为26.7%,在此以下,仅为5%。两者差异极显著(P<0.01)。虽缺少早期测定值可低估MIS,但应用校正方法可准确作出估测。
The time-activity curves of serum creatine phosphokinase isoenzyme (CPK-MB) in 35 patients with acute myocardial infarction were dynamically assayed to explore the clinical significance of estimating the extent of myocardial infarction (MIS) and the lack of early detection of the value of MIS Influence degree, correction method The results showed that the size of MIS is an important factor in the prognosis. When MIS is above 60CPK-MB-g-Eq, the case fatality rate is 26.7%, and below 5%. The difference was significant (P <0.01). Although the lack of early measurement can underestimate the MIS, but the correction method can be accurately estimated.